Primary Site >> Biliary tract Cancer

Gene >> IL32

Journal: Oncogene. 1998 Dec 10;17(23):3045-54.
Title: Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor.
Author: Date, K|Matsumoto, K|Kuba, K|Shimura, H|Tanaka, M|Nakamura, T
PMID: 9881707
Journal: Cancer Gene Ther. 2004 Jun;11(6):431-40.
Title: Gallbladder cancer treatment using adenovirus expressing the HGF/NK4 gene in a peritoneal implantation model.
Author: Tanaka, Toshihiro|Shimura, Hideo|Sasaki, Takamitsu|Narumi, Kou|Maemondo, Makoto|Nukiwa, Toshihiro|Matsumoto, Kunio|Nakamura, Toshikazu|Ikeda, Seiyo
PMID: 15118756
Journal: Dig Dis Sci. 2013 Jun;58(6):1636-43.
Title: NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells.
Author: Ge, Xianxiu|Wang, Youli|Wang, Yun|Li, Quanpeng|Yu, Hong|Miao, Lin
PMID: 23314853
Journal: Oncol Rep. 2013 Jul;30(1):448-54.
Title: NK4 regulates 5-fluorouracil sensitivity in cholangiocarcinoma cells by modulating the intrinsic apoptosis pathway.
Author: Ge, Xianxiu|Wang, Youli|Li, Quanpeng|Yu, Hong|Ji, Guozhong|Miao, Lin
PMID: 23619566